See also this year's filing and all EDGAR filings for this company.
PDF Report 0001048477_2022_Biomarin_Pharmaceutical_INC.pdf
Logs
Graph
Absolute values for 0001048477, Biomarin Pharmaceutical INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,274,385,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 584,851,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,035,461,000 |
| 3 | remainder_Assets | 2,108,628,000 |
| 4 | LiabilitiesCurrent | 539,822,000 |
| 5 | LiabilitiesNoncurrent | 98,519,000 |
| 6 | remainder_Liabilities | 1,094,244,000 |
| 7 | CostOfGoodsAndServicesSold | 457,043,729 |
| 8 | SellingGeneralAndAdministrativeExpense | 794,324,021 |
| 9 | ResearchAndDevelopmentExpense | 629,333,379 |
| 10 | remainder_Expenses | -353,768,123 |
| 11 | remainder_Revenues | 1,850,738,077 |
| 12 | remainder_NetIncome | 22,375,869 |
| 13 | remainder_ComprehensiveNetIncome | 2,244,590 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 6,003,325,000 |
| 1 | Liabilities | 1,732,585,000 |
| 2 | Expenses | 1,526,933,006 |
| 3 | Revenues | 1,850,738,077 |
| 4 | StockholdersEquity | 4,270,740,000 |
| 5 | NetIncome | 346,180,940 |
| 6 | ComprehensiveNetIncome | 347,303,235 |
| 7 | BaseVar | 5,569,100,771 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.50 |
| 9 | EconomicCapitalRatio | 3.35 |
Edgar->Model Mapping
Feature Distribution
Change over Time
